Trial intelligence / Profile preview

Treatment of elevated pulmonary arterial pressure with inhaled iloprost in ventilated neonates

2004-001551-11Phase 2Active

Sponsor
Skåne University Hospital
Start
Aug 2004
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of iloprost in pulmonary hypertension (PH), respiratory distress syndrome (RDS) and Meconium aspiration syndrome (MAS), sponsored by Skåne University Hospital. Primary endpoints: Respiratory function parameters, Cardiovascular function parameters and 2 more. Started Aug 2004; status: active.

02

Drugs

iloprost
03

Conditions

pulmonary hypertension (PH)respiratory distress syndrome (RDS)Meconium aspiration syndrome (MAS)

Beyond the preview

Go deeper on 2004-001551-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001551-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call